EUMENTIS THERAPEUTICS

eumentis-therapeutics-logo

Eumentis is a biopharmaceutical company that develops novel drugs for the treatment of neurodevelopmental and neurodegenerative disorders. The Company's lead product candidate, EM-036, is a novel proprietary nitro-aminoadamantane N-methyl-d-aspartate type-glutamate receptor (NMDAR) antagonist first being developed for the treatment of children and adults with Autism Spectrum Disorder (ASD). EuMentis is also exploring other indications for EM-036.

#SimilarOrganizations #People #Financial #Website #More

EUMENTIS THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2019-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.eumentistx.com

Total Employee:
1+

Status:
Active

Total Funding:
5.9 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS


Similar Organizations

orig3n-logo

ORIG3N

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

praxis-precision-medicines-logo

Praxis Precision Medicines

Praxis Precision Medicines offers drug development services.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Current Employees Featured

james-w-larrick_image

James W. Larrick
James W. Larrick CSO @ Eumentis Therapeutics
CSO

randall-marshall_image

Randall Marshall
Randall Marshall Chief Medical Officer @ Eumentis Therapeutics
Chief Medical Officer
2020-10-01

mark-tepper_image

Mark Tepper
Mark Tepper President & CEO @ Eumentis Therapeutics
President & CEO
2019-08-01

Investors List

social-starts_image

Social Starts

Social Starts investment in Series A - Eumentis Therapeutics

joyance-partners_image

Joyance Partners

Joyance Partners investment in Series A - Eumentis Therapeutics

small-business-innovation-research_image

Small Business Innovation Research

Small Business Innovation Research investment in Grant - Eumentis Therapeutics

life-science-angels_image

Life Science Angels

Life Science Angels investment in Seed Round - Eumentis Therapeutics

Official Site Inspections

http://www.eumentistx.com Semrush global rank: 6.14 M Semrush visits lastest month: 1.32 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Eumentis Therapeutics" on Search Engine